Source: BioSpace

ASCEND Therapeutics: Egalet's Partner ASCEND Therapeutics, Inc. Begins Promotion Of SPRIX Nasal Spray

Life Sciences Jobs ...

Read full article »
ASCEND Therapeutics's Competitors | ASCEND Therapeutics's News | ASCEND Therapeutics's Financials
Stay up-to-date with the latest news on ASCEND Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Nicholas Hart's photo - President & CEO of ASCEND Therapeutics

President & CEO

Nicholas Hart

CEO Approval Rating

81/100

Read more
Stay up-to-date with the latest news on ASCEND Therapeutics